Castration-resistance is the primary cause of mortality from prostate cancer. However, the molecular mechanisms of castration-resistance in prostate cancer remains obscure. Our previous studies showed that ERG overexpression is critically associated with prostate cancer invasiveness and metastases [J Mol Diagn 2010; Clin Cancer Res 2012]. Our recent investigations further confirmed: (1) CircRNA-GLIS3 expression was significantly higher in patients with castration-resistant prostate cancer, compared with androgen dependent prostate cancer. (2) CircRNA-GLIS3 could function as a competing endogenous RNA to regulate ERG expression by sponging miR-145 in inducing castration-resistance in prostate cancer cells. Herein, based on these findings and the close correlation between ERG and epigenetic regulation shown by our recent publication, we speculate and present the novel mechanisms underlying circRNA-GLIS3-inducing castration-resistance in prostate cancer: circRNA-GLIS3 may act as a competing endogenous RNA, effectively becoming a sink for miR-145, thereby modulating the derepression of ERG. Subsequently, histone H3K27 methylation in its promoter is increased, thus contributes to castration-resistance in prostate cancer. Based on a series of molecular, in vitro/in vivo, and clinical sample experiments, our present study makes endeavor to elucidate the molecular mechanisms of castration-resistance in prostate cancer focusing on circGLIS3→ceRNA→miRNAs→ERG regulatory network. These results may provide novel and imperative molecular targets for the intervention of castration-resistant prostate cancer.
去势抵抗是前列腺癌(PC)致死的重要原因,但机制未明。我们的前期研究证实ERG过表达与PC侵袭进展密切相关[J Mol Diagn 2010; Clin Cancer Res 2012]。进一步研究发现,去势抵抗型PC中circRNA-GLIS3表达明显高于激素依赖型PC;circGLIS3可吸附miR145,调控ERG表达,促进PC细胞去势抵抗。鉴于前期发现ERG与表观遗传调控存在密切关联,我们提出circGLIS3促进PC去势抵抗新机制:高表达circGLIS3通过发挥ceRNA活性,减弱miR145对ERG抑制,组蛋白H3K27甲基化,促进PC去势抵抗。本项目拟通过分子、体外及动物和临床标本等水平的一系列实验,力图解析以circGLIS3→ceRNA→miRNAs→ERG通路为核心的PC去势抵抗分子机制,为PC的治疗提供重要的分子干预靶点。
去势抵抗是前列腺癌(PC)致死的重要原因,但机制未明。本项目在前期工作基础上,紧紧围绕“circGLIS3通过结合miR-145,减轻miR-145对ERG的抑制作用,激活ERG信号通路促进前列腺癌去势抵抗”这一科学问题,从circGLIS3的新调控机制入手,从分子水平阐述circGLIS3调控ERG的机制。体外实验水平,进一步明确了circGLIS3结合miR-145调控ERG的表达,从而促进去势抵抗性前列腺癌细胞的增殖、侵袭、迁移能力;动物实验水平,明确了异常表达的circGLIS3对去势抵抗性前列腺癌细胞在肿瘤成瘤及转移能力的影响;在临床水平,发现和证实circGLIS3的高表达在预测肿瘤进展中的价值以及作为独立的预测预后因素。项目按计划顺利完成,共发表2篇论文,其中SCI论著1篇(IF:27.401),国内核心期刊论著1篇。
{{i.achievement_title}}
数据更新时间:2023-05-31
视网膜母细胞瘤的治疗研究进展
原发性干燥综合征的靶向治疗药物研究进展
Wnt 信号通路在非小细胞肺癌中的研究进展
内质网应激在抗肿瘤治疗中的作用及研究进展
上转换纳米材料在光动力疗法中的研究进展
UTX缺失促进转移性去势抵抗前列腺癌形成的分子机制
lncRNA CCAL作为ceRNA调控MAPK促进胃癌进展的机制研究
去势条件下癌相关成纤维细胞异常增殖与活化促进去势抵抗型前列腺癌形成的机制研究
转录因子BTF3促进去势抵抗性前列腺癌恶性生长的分子机制研究